Bruce & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bruce & Co’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100,000	Closed	-$170K	–	46
2018 Q3	$170K	Hold	100,000	–	–	0.03%	42
2018 Q2	$174K	Hold	100,000	–	–	0.03%	43
2018 Q1	$183K	Hold	100,000	–	–	0.04%	41
2017 Q4	$223K	Hold	100,000	–	–	0.05%	46
2017 Q3	$290K	Hold	100,000	–	–	0.06%	48
2017 Q2	$445K	Buy	+100,000	New	+$412K	0.1%	43

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCM

Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bruce & Co's SGYP Position: Q4 2018 in Review

Bruce & Co sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 100,000 shares — an estimated $170K sold.

Bruce & Co first reported a position in SGYP in Q2 2017 and held it in 6 quarters. The position peaked at $445K in Q2 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Bruce & Co reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Bruce & Co sold 100,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $170K.
Bruce & Co first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 6 quarters.
Bruce & Co's Synergy Pharmaceuticals, Inc Common Stock position peaked at $445K in Q2 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Bruce & Co's 13F filing for Q4 2018, filed 15 Feb 2019.